Compare CVS Health Corp (CVS) vs FuelCell Energy Inc (FCEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs FuelCell Energy Inc — how do they compare? CVS Health Corp trades at $106.05 (market cap $135.48B), while FuelCell Energy Inc trades at $20.11 (market cap $1.71B). The key difference: CVS Health Corp is far larger — about 79.2× FuelCell Energy Inc's market cap, and CVS Health Corp pays a 2.51% dividend while FuelCell Energy Inc pays none. Which is the better fit depends on your goals.
| CVS | FCEL | |
|---|---|---|
Market Cap | $135.48B | $1.71B |
Sector | Health | Industrials |
52-Week High | $106.18 | $36.01 |
52-Week Low | $58.75 | $3.92 |
Enterprise Value | $202.02B | $1.56B |
Dividend Yield | 2.51% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.
The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.
FuelCell Energy (FCEL) trades at $19.08, down 9.27% in the last session, as the stock consolidates following recent volatility. The company reported mixed Q1 2026 results with an earnings miss but continues to show revenue growth, with 2025 revenue reaching $158.16M. Technical indicators show a bearish trend with key support at $17-18 levels. Recent developments include a strategic partnership with Siemens to scale clean power solutions and a $225 million stock offering that caused temporary dilution concerns.
FCEL presents a high-risk opportunity with strong growth potential in the fuel cell sector but faces significant fundamental challenges. The company maintains negative profitability metrics and cash burn, though recent partnerships and data center demand provide catalysts. Analyst consensus is mixed with a $20.75 price target representing 8.8% upside, but investors should weigh the growth narrative against persistent losses and dilution risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About FuelCell Energy Inc
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products, which efficiently convert chemical energy in fuels into electricity through a series of chemical reactions. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company generates a majority of its revenue from the United States followed by South Korea.
Read more on FCEL →
